Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
about
Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Is the risk of progressive mul ...... ients with multiple sclerosis?
@ast
Is the risk of progressive mul ...... ients with multiple sclerosis?
@en
Is the risk of progressive mul ...... ients with multiple sclerosis?
@nl
type
label
Is the risk of progressive mul ...... ients with multiple sclerosis?
@ast
Is the risk of progressive mul ...... ients with multiple sclerosis?
@en
Is the risk of progressive mul ...... ients with multiple sclerosis?
@nl
prefLabel
Is the risk of progressive mul ...... ients with multiple sclerosis?
@ast
Is the risk of progressive mul ...... ients with multiple sclerosis?
@en
Is the risk of progressive mul ...... ients with multiple sclerosis?
@nl
P2093
P2860
P1433
P1476
Is the risk of progressive mul ...... ients with multiple sclerosis?
@en
P2093
Christoph Heesen
Ingo Kleiter
Jan-Gerd Tenberge
Julia Krämer
Sven G Meuth
Tobias Ruck
P2860
P304
P356
10.1371/JOURNAL.PONE.0174858
P407
P577
2017-04-13T00:00:00Z